Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-50.89	-288.18	586.85
Graham Fair Price	4.32	821.11	787.10
PEG	-93.26	0.34	4.99
Price/Book	5.11	4.89	4.65
Price/Cash Flow	67.65	-110.21	-340.65
Prices/Earnings	-6.59	-70.80	75.79
Price/Sales	24.45	35.22	28.30
Price/FCF	67.65	-110.21	-340.65
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-25.54	0.20	0.27
Operating Margin	-2218.77	-0.19	< 0.005
ROA	18.06	-0.01	0.01
ROE	0.02	-0.02	12.53
ROIC	< 0.005	-0.03	-3699.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.34	-85.28
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.21	-18.26	-1411.57
EPS QOQ	0.15	-2.11	1286.76
FCF QOQ	-2.73	-2.20	19.64
Revenue QOQ	0.09	-0.17	97.51
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	195.35	215.83	10.48
Days Sales Outstanding (DSO)	53.51	66.49	24.25
Inventory Turnover	0.46	0.42	-9.49
Debt/Capitalization	0.04	0.03	-5.41
Quick Ratio	2.82	2.02	-28.25
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1339.86	1317.65	-1.66
Cash	233.74	179.82	-23.07
Capex	-55.00	-57.71	-4.92
Free Cash Flow	-18.29	-58.43	-219.52
Revenue	220.18	182.88	-16.94
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.56	4.36	-21.64
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-17.29	5.56	-67.83
Naive Interpretation	Member

06 - Financial Health · Bad

Rating